Valor

Valo Health is a technology company that utilizes human-centric data and artificial intelligence to transform the drug discovery and development process. The company's proprietary Opal Computational Platform integrates machine learning and high-throughput data to identify novel drug targets and accelerate the development of small molecule therapeutics. Valo focuses on high-burden disease areas including cardiovascular disease, oncology, and neurodegeneration. By leveraging a closed-loop system of data and computation, the company aims to reduce the time, cost, and failure rate associated with traditional drug development. Valo has established significant partnerships with major pharmaceutical companies to apply its platform to complex disease biology.